Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

MBSR und NLP, Stillen nach der Geburt und Depression (postpartum)

30. Oktober 2026 aktualisiert von: Aysegul Kilicli

die Auswirkung von MBSR- und NLP-Anwendungen auf Müdigkeit, Schlafqualität, Stillzeit und postpartale Depression in der Zeit nach der Geburt nach einem Kaiserschnitt

The postnatal period is a risky period in which mothers experience regressive and progressive changes and rapid biopsychosocial changes. Since this process affects not only the mother but also the family, mothers are under intense stress due to adaptation to the changes that occur in this period.

Studienübersicht

Status

Abgeschlossen

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

The postnatal period is a risky period in which retrogressive and progressive changes and rapid biopsychosocial changes occur in mothers. Since this process affects not only the mother but also the family, mothers are under intense stress due to adaptation to the changes occurring in this period. Studies have reported that the most common physical problems in the early postpartum period after caesarean section are pain in the incision area, difficulty in caring for the baby alone, activity intolerance, fatigue, insomnia, breastfeeding problems (such as nipple or lack of milk), mastitis and abdominal tension/gas. As important as it is to reduce postpartum symptoms after caesarean section, it is also important to support and maintain breastfeeding. However, postpartum symptoms such as pain, fatigue and negative effects of anaesthesia after caesarean section negatively affect the breastfeeding process and lead to a delay in the onset of lactation.

When the literature was examined, no study was found that examined the effects of mindfulness-based stress reduction programme and neurolinguistic programme on fatigue, sleep quality, lactation and depression in the postpartum long term.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

90

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

  • Türkei (türkiye)
    • Eyalet/Yerleşke
      • Sanliurfa, Eyalet/Yerleşke, Türkei (türkiye), 63000
        • Şanlıurfa training and research hospital

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

19 Jahre bis 35 Jahre (Erwachsene)

Akzeptiert gesunde Freiwillige

Ja

Studienberechtigte Geschlechter

Weiblich

Beschreibung

Inclusion Criteria:

  • 19-35 years old
  • caesarean section
  • primiparous
  • breastfeeding women

Exclusion Criteria:

  • women who refused to participate in the research.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Sonstiges
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Mindfulness-based stress reduction program

MBSR; Mindfulness-based stress reduction program. 8 weeks of practice once a week for 20 minutes each. Mindfulness-based stress reduction practices will be carried out online. Mothers will actively participate.
Verhalten: MBSR

20 minutes once a week for 8 weeks

Andere Namen:
  • Auf Achtsamkeit basierendes MBSR-Stressreduktionsprogramm
Experimental: Neurolinguistic programming

NLP; Neurolinguistic programming 8 weeks of practice once a week for 20 minutes each. Neurolinguistic programming will be carried out online. Mothers will actively participate.
Verhalten: NLP

NLP Neurolinguistic programming, 20 minutes once a week for 8 weeks

Andere Namen:
  • NLP Neurolinguistisches Programmieren
Experimental: control

control; MBSR and NLP applications will not be performed. Mothers will be monitored online every week.
Verhalten: control

control group, no practice,

Andere Namen:
  • Kontrollgruppe

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Visual Analogue Scale for Fatigue (VAS-F)
Zeitfenster: before the first application

Visual Analogue Scale for Fatigue (VAS-F), The most positive expression of the fatigue sub-dimension is 0 and the most negative expression is 10, the most negative expression of the energy sub-dimension is 0 and the most positive expression is 10.
before the first application
Visual Analogue Scale for Fatigue (VAS-F)
Zeitfenster: Week 4, following the intervention administered on that day

Visual Analogue Scale for Fatigue (VAS-F) The most positive expression of the fatigue sub-dimension is 0 and the most negative expression is 10, the most negative expression of the energy sub-dimension is 0 and the most positive expression is 10.
Week 4, following the intervention administered on that day
Visual Analogue Scale for Fatigue (VAS-F)
Zeitfenster: Week 8, following the final intervention

Visual Analogue Scale for Fatigue (VAS-F) The most positive expression of the fatigue sub-dimension is 0 and the most negative expression is 10, the most negative expression of the energy sub-dimension is 0 and the most positive expression is 10.
Week 8, following the final intervention
Pittsburgh Sleep Quality Index (PSQI)
Zeitfenster: before the first application

Pittsburgh Sleep Quality Index (PSQI) Each item is evaluated as 0-3 points and the sum of the 7 subcomponents constitutes the PDQI score. The lowest score of the scale is 0 and the highest score is 21. A total PDQI score of ≤5 indicates good sleep and >5 indicates poor sleep.
before the first application
Pittsburgh Sleep Quality Index (PSQI)
Zeitfenster: week 4, following the intervention administered on that day

Pittsburgh Sleep Quality Index (PSQI) Each item is evaluated as 0-3 points and the sum of the 7 subcomponents constitutes the PDQI score. The lowest score of the scale is 0 and the highest score is 21. A total PDQI score of ≤5 indicates good sleep and >5 indicates poor sleep.
week 4, following the intervention administered on that day
Pittsburgh Sleep Quality Index (PSQI)
Zeitfenster: week 8, , following the final intervention

Pittsburgh Sleep Quality Index (PSQI) Each item is evaluated as 0-3 points and the sum of the 7 subcomponents constitutes the PDQI score. The lowest score of the scale is 0 and the highest score is 21. A total PDQI score of ≤5 indicates good sleep and >5 indicates poor sleep.
week 8, , following the final intervention
Edinburgh Postpartum Depression Scale (EPDS)
Zeitfenster: before the first application

Edinburgh Postpartum Depression Scale (EPDS) The scale is a 4-point Likert-type scale consisting of 10 items. Responses consisting of four options are scored between 0 and 3. A minimum of 0 and a maximum of 30 points can be obtained from the scale. The cut-off point of the scale is 13 points and above for women and 10 points and above for men, and above this point indicates the presence of depression.
before the first application
Edinburgh Postpartum Depression Scale (EPDS)
Zeitfenster: week 4, following the intervention administered on that day

Edinburgh Postpartum Depression Scale (EPDS) The scale is a 4-point Likert-type scale consisting of 10 items. Responses consisting of four options are scored between 0 and 3. A minimum of 0 and a maximum of 30 points can be obtained from the scale. The cut-off point of the scale is 13 points and above for women and 10 points and above for men, and above this point indicates the presence of depression.
week 4, following the intervention administered on that day
Edinburgh Postpartum Depression Scale (EPDS)
Zeitfenster: week 8, following the final intervention

Edinburgh Postpartum Depression Scale (EPDS) The scale is a 4-point Likert-type scale consisting of 10 items. Responses consisting of four options are scored between 0 and 3. A minimum of 0 and a maximum of 30 points can be obtained from the scale. The cut-off point of the scale is 13 points and above for women and 10 points and above for men, and above this point indicates the presence of depression.
week 8, following the final intervention
Breastfeeding Self-Efficacy Scale (BSES)
Zeitfenster: before the first application

Breastfeeding Self-Efficacy Scale (BSES) The scale consists of 14 items, five-point Likert type. The items of the scale are evaluated on a scale from '1=never sure' to 5=always sure'. A minimum of 14 points and a maximum of 70 points can be obtained from the scale. All items are positive. The higher the score obtained from the scale, the higher the breastfeeding self-efficacy.
before the first application
Breastfeeding Self-Efficacy Scale (BSES)
Zeitfenster: week 4, following the intervention administered on that day

Breastfeeding Self-Efficacy Scale (BSES) The scale consists of 14 items, five-point Likert type. The items of the scale are evaluated on a scale from '1=never sure' to 5=always sure'. A minimum of 14 points and a maximum of 70 points can be obtained from the scale. All items are positive. The higher the score obtained from the scale, the higher the breastfeeding self-efficacy.
week 4, following the intervention administered on that day
Breastfeeding Self-Efficacy Scale (BSES)
Zeitfenster: week 8, following the final intervention

Breastfeeding Self-Efficacy Scale (BSES) The scale consists of 14 items, five-point Likert type. The items of the scale are evaluated on a scale from '1=never sure' to 5=always sure'. A minimum of 14 points and a maximum of 70 points can be obtained from the scale. All items are positive. The higher the score obtained from the scale, the higher the breastfeeding self-efficacy.
week 8, following the final intervention
Exclusive breastfeeding status
Zeitfenster: before the first application

Exclusive breastfeeding status (yes or no)
before the first application
Exclusive breastfeeding status
Zeitfenster: week 4, following the intervention administered on that day

Exclusive breastfeeding status (yes or no)
week 4, following the intervention administered on that day
Exclusive breastfeeding status
Zeitfenster: week 8, following the final intervention

Exclusive breastfeeding status (yes or no)
week 8, following the final intervention

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Aysegul Kilicli

Ermittler

  • Studienleiter: AYŞEGÜL KILIÇLI, Dr., Muş Alparslan University

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

8. Oktober 2024

Primärer Abschluss (Tatsächlich)

1. Februar 2025

Studienabschluss (Tatsächlich)

1. Februar 2025

Studienanmeldedaten

Zuerst eingereicht

3. Oktober 2024

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

3. Oktober 2024

Zuerst gepostet (Tatsächlich)

8. Oktober 2024

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

3. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

30. Oktober 2026

Zuletzt verifiziert

1. Oktober 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Schlüsselwörter

Zusätzliche relevante MeSH-Bedingungen

Andere Studien-ID-Nummern

  • Mauniv

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

JA

Beschreibung des IPD-Plans

All

IPD-Sharing-Zeitrahmen

8 October 2024 - 30 October 2025

IPD-Sharing-Zugriffskriterien

8 October 2024 - 30 October 2025

Art der unterstützenden IPD-Freigabeinformationen

  • STUDIENPROTOKOLL
  • SAFT
  • ICF
  • ANALYTIC_CODE
  • CSR

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren